To view this email as a web page, click here.

Cancer Deaths Cost the United States Billions

A new study estimated that cancer deaths in 2015 resulted in billions in lost earnings in the United States.

Could Adding Bortezomib Have Benefit for High-Risk Follicular Lymphoma?

The CALGB 50904 trial tested the addition of bortezomib to ofatumumab and bendamustine in patients with previously untreated high-risk follicular lymphoma.

IN CASE YOU MISSED IT

Combination Immunotherapy Efficacy in Lung Cancer May Differ by Patient Sex

A study in the Journal of the National Cancer Institute evaluated responses in men vs women to combination chemotherapy and a PD-1 or PD-L1 inhibitor.

Read more

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.